PNV 1.68% $2.34 polynovo limited

PNV - Chart, page-237

  1. 1,807 Posts.
    lightbulb Created with Sketch. 359
    Jevalent, I think that there is uncertainty about how long it will take before a contract is signed but I've no doubt that one will be signed.

    The uncertainty arises because the deal looks to have become bigger than was first imagined and, therefore, more complicated. They are going to "jointly develop a range of medical devices." That is, "new generation devices specific to breast aesthetics and reconstruction." My understanding was that previously the message from Polynovo was that just component technology would be provided for the medical device company to use e.g. breast sling. Given this, it becomes more complicated to resolve contractual issues of financial contribution and return.

    I do find the company's future quite exciting to contemplate.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.